powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1124414180
Ana Carolina Costa Monteiro
M.D./PHD
Pulmonary Disease
Los Angeles,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
CCN 050112
Hospital
CCN 050262
Hospital
CCN 050481
Hospital
CCN 050549
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
108
Beneficiaries
—
Total drug cost
$44K
Distinct drugs
4
Brand share
84.3%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter
48 claims
Albuterol Sulfate
32 claims
Fluticasone Propionate
17 claims
Budesonide/Glycopyr/Formoterol
11 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
276
Unique beneficiaries
—
Total services
431
Distinct HCPCS
10
Medicare payment
$36K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 901 Pulmonary Disease providers in CA — below median (cohort median 927).
QUALITY · MIPS · 2024
Final MIPS score
87.5
Quality
79.4
Cost
73.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.53%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$38
Payment records
1
By payment type
Food and Beverage
$38